Novartis AG (NVS) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $146.69 (-0.78%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
NVS vs Sector & Market
| Metric | NVS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.50 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | -3.9% | +1150.3% | +14.9% |
| P/E Ratio | 19.86 | 6.85 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $13.97B | $14.14B | $14.36B | 4 |
| 2026-09-30 | $14.15B | $14.52B | $14.77B | 2 |
| 2026-12-31 | $14.39B | $14.77B | $15.02B | 3 |
| 2027-03-31 | $13.46B | $13.82B | $14.05B | 3 |
| 2027-06-30 | $14.03B | $14.40B | $14.64B | 2 |
| 2027-09-30 | $14.26B | $14.63B | $14.88B | 2 |
| 2027-12-31 | $14.37B | $14.76B | $15.00B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $2.10 | $2.19 | $2.28 | 2 |
| 2026-09-30 | $2.19 | $2.26 | $2.31 | 1 |
| 2026-12-31 | $2.11 | $2.19 | $2.23 | 1 |
| 2027-03-31 | $2.17 | $2.25 | $2.30 | 1 |
| 2027-06-30 | $2.29 | $2.37 | $2.42 | 1 |
| 2027-09-30 | $2.33 | $2.41 | $2.46 | 1 |
| 2027-12-31 | $2.34 | $2.42 | $2.47 | 1 |
Frequently Asked Questions
What is the analyst consensus for NVS?
The consensus among 2 analysts covering Novartis AG (NVS) is Buy with an average price target of $127.00.
What is the highest price target for NVS?
The highest analyst price target for NVS is $143.00.
What is the lowest price target for NVS?
The lowest analyst price target for NVS is $112.00.
How many analysts cover NVS?
2 analysts have issued ratings for Novartis AG in the past 12 months.
Is NVS a buy or sell right now?
Based on 2 analyst ratings, NVS has a consensus rating of Buy (2.50/5) with a -3.9% upside to the consensus target of $127.00.
What are the earnings estimates for NVS?
Analysts estimate NVS will report EPS of $2.19 for the period ending 2026-06-30, with revenue estimated at $14.14B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.